Emerging Infectious
     Diseases Toolboxes
  Emerging Infectious
     Diseases Toolboxes
  Seminars/Classes/Webinars
     Check the Biosafety Calendar
  Seminars/Classes/Webinars
     Check the Biosafety Calendar
  Animal Biosafety Videos
  Animal Biosafety Videos
  Intro to Biosafety Curriculum
  Intro to Biosafety Curriculum
  Biosafety Links
  Biosafety Links
  Training Tools & Resources
  Training Tools & Resources
  Viral Vector Tools
  Viral Vector Tools

BIOSAFETY RESOURCES

BIOSAFETY RESOURCES

Resources with keywords: mmr



Measles Outbreak in Texas
Texas HHS

Includes information on who should be vaccinated, how to find vaccines, free vaccines, etc.

Measles
TEPHI (Texas Epidemic Public Health Institute)

Good background information and outbreak updates on Measles outbreak in Texas and NM.

Expanding Measles Outbreak in the United States and Guidance for the Upcoming Travel Season
CDC / Health Alert Network (HAN)
7 March 2025

Includes recommendations for clinicians, public health departments and travellers.

Measles (Rubeola): Lab Tools
CDC

includes speicmen collection, storage, shipment and serology practices for measles

keywords: laboratory, measles, mmr
Increase in Global and Domestic Measles Cases and Outbreaks: Ensure Children in the United States and Those Traveling Internationally 6 Months and Older are Current on MMR Vaccination
CDC Health Alert Network (HAN)
18 March 2024

Related to 58 confirmed cases of measles in US in 2024.

keywords: measles, mmr
Mumps
CDC Pink Book

Epidemiology and Prevention of Vaccine-Preventable Diseases

keywords: mmr, mumps
Rubella
CDC Pink Book

Epidemiology and Prevention of Vaccine-Preventable Diseases

keywords: mmr, rubella
Measles
CDC Pink Book

Epidemiology and Prevention of Vaccine-Preventable Diseases

keywords: measles, mmr
Manual for the Laboratory-based Surveillance of Measles, Rubella, and Congenital Rubella Syndrome
TechNet-21.org
1 June 2018

Chapter 3- Includes Safety procedures for incoming clinical samples.
Third edition, June 2018

Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination
Human Vaccines & Immunotherapeutics
12 May 2016

Baldo A, Galanis E, Tangy F, Herman P.
The use of recombinant MV vector has to comply with various regulatory requirements, particularly relating to the assessment of potential risks for human health and the environment. The present article highlights the main characteristics of MV and recombinant MV vectors used for vaccination and virotherapy and discusses these features from a biosafety point of view.

Go to Top